Data & Digital Innovation for Climate & Health
Joanna Shields, CEO BenevolentAI, joined the Wellcome Trust Panel at the World Economic forum to discuss opportunities for data and digital innovation to impact positively climate and health.
Text & Data Mining in Drug Discovery: A Conversation with Springer Nature
Hear Mark Davies, SVP Informatics and Data, speak to Springer Nature about how BenevolentAI is leveraging the scientific literature to expedite drug discovery.
Innovation Week: pushing the boundaries of AI in drug discovery
BenevolentAI’s Innovation Week enables our team to reflect, build and test new ideas and push the boundaries of AI in drug discovery.
BenevolentAI · AI-Enabled Drug Discovery
Advanced technologies, combined with an exponential increase in biomedical data and research, provide an unparalleled opportunity to unravel the mysteries of diseases that have gone untreated for too long.
Contact us →
Company Registration: R.C.S. Luxembourg: B255412
Terms & Conditions
Privacy & Cookies Policy
WHAT WE DO
DATA DIVERSITY INITIATIVE
WORKING AT BENEVOLENT
FIND A JOB
NEWS & MEDIA